Skip to content

Clinical trials

Recruiting Phase 1 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Status: Recruiting Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20182
20202
20217
202211
202311
202413
202520
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting77

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital of Guangzhou Medical University5
Chongqing Precision Biotech Co., Ltd3
Emory University3
City of Hope Medical Center2
Eli Lilly and Company2
M.D. Anderson Cancer Center2
Ohio State University Comprehensive Cancer Center2
Revolution Medicines, Inc.2
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2
A&G Pharmaceutical Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms77
Carcinoma, Non-Small-Cell Lung37
Breast Neoplasms23
Pancreatic Neoplasms19
Colonic Neoplasms14
Neoplasm Metastasis13
Neoplasms13
Esophageal Neoplasms12
Stomach Neoplasms12
Ovarian Neoplasms11

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.